Imported Diseases-temp

By | HOP SING GRASSHOPPER | In the following paragraphs, I will do a deep dive about Three-Thousand Meters into the rarely discussed subject: American Imported Diseases, which are tariff free imports from the disease factories from around the world. The notion that American Imported Diseases not only effects humans, but all biology in our biosphere is true, and is just another brick in the wall of mortality! The American state of porous borders encourage policy gaps that let infectious diseases slip into The United States of America, from around the world. On a humid morning in 2014, a man named John Billy Doe walked into a Dallas, Texas — emergency room with a fever, was sent home with antibiotics, and became the first person diagnosed with Ebola on American soil. He had flown from Liberia days earlier, passing through an airport screening system that checked his temperature but had no way to see the virus incubating in his blood. Two nurses who cared for him later contracted the disease themselves. The episode became a case study in something public health officials had warned about for years: America’s defenses against imported infectious disease are not a wall. They are a patchwork, stitched together from underfunded agencies, jurisdictional gaps, and political decisions made for reasons that have little to do with epidemiology. This essay examines how that patchwork lets pathogens through — not through any single failure, but through a slow accumulation of choices about what to fund, what to monitor, and what to ignore. The first line of defense against an imported outbreak is knowing it’s coming before it arrives. That job belongs, in large part, to the CDC’s Division of Global Migration and Quarantine, which operates twenty quarantine stations at ports of entry across the country. It sounds like a formidable operation until you learn the numbers: those twenty stations are responsible for screening travelers arriving through more than three hundred ports of entry, covering hundreds of millions of passenger arrivals a year. The math does not work, and it has not worked for a long time. A 2015 Government Accountability Office report found that CDC quarantine stations were understaffed and lacked standardized procedures for identifying and responding to sick travelers. Nearly a decade later, similar staffing and funding shortfalls were still being flagged by public health researchers during the mpox and COVID-19 responses. Is this situation by chance or deliberate? Could it be agenda driven, only the people we employ to manage our public affairs know the true answer!

Public Health Surveillance

This is not a partisan failure so much as a chronic one. Public health surveillance is the kind of infrastructure that only earns political attention after it has already failed — after the outbreak, not before it. Between crises, funding for global disease surveillance tends to shrink, staff get reassigned, and international partnerships wither. The CDC’s overseas offices, which historically served as an early-warning network by placing American epidemiologists inside foreign health ministries, have seen their budgets rise and fall with the political winds in Washington rather than with the actual trajectory of global disease risk. When those offices are hollowed out, the United States loses its eyes and ears in the places where novel pathogens are most likely to emerge — dense urban centers in Southeast Asia, wildlife markets in Central Africa, refugee camps strained by conflict. By the time a disease is spreading fast enough to make headlines, it is usually already several steps ahead of the systems meant to catch it. Airport screening has a way of looking more reassuring than it is. Infrared thermometers pointed at foreheads, questionnaires asking travelers to self-report symptoms, health declaration cards handed out on planes — these measures photograph well, but public health researchers have repeatedly found them to be blunt instruments. Fever screening misses asymptomatic and pre-symptomatic carriers almost by definition, and it is trivially defeated by anyone taking ibuprofen before landing. A widely cited modeling study published during the COVID-19 pandemic estimated that entry screening alone would catch only a minority of infected travelers, because incubation periods routinely stretch well beyond the window in which a fever would show up. The 2014 Ebola screening program at five U.S. airports checked over half a million travelers and found active fever in only a small handful — not because the system worked, but because fever is a poor proxy for infection risk in the early stages of many diseases. The deeper problem is structural: no single federal agency owns the full pipeline from “traveler boards a plane overseas” to “traveler is monitored at home after arrival.” The sad part is that we spend countless billions on equipment and personnel.

Quarantine and Isolation

US Customs and Border Protection controls the physical checkpoint. The CDC has authority over quarantine and isolation but limited on-the-ground enforcement capacity. State and local health departments are supposed to pick up contact tracing and follow-up monitoring once a traveler leaves the airport, but they operate with wildly uneven budgets and staffing depending on which state a plane happens to land in. A traveler flagged as a contact of a confirmed case in New York enters a very different follow-up system than the same traveler landing in a rural county with two public health nurses on staff. Disease does not respect that patchwork, even when policy does. Some of the clearest examples of policy failing public health come not from neglect but from active political interference. During the early weeks of the COVID-19 pandemic, travel restrictions were announced and walked back in ways that seemed to track domestic political messaging as much as case data. Testing capacity, which should have scaled in the earliest days when containment was still plausible, was instead bottlenecked by a faulty CDC-developed test kit and a slow FDA authorization process for alternatives — a bureaucratic delay that cost the country weeks it could not afford. Public health historians have pointed to this stretch, roughly February 2020, as the period when containment slipped irreversibly into mitigation, and it happened not because the science was unclear but because the machinery of government moved too slowly and, at points, too cautiously to keep pace with a fast-moving virus. There is also a long history of federal officials softening or delaying public health guidance because it was politically inconvenient — a pattern documented across multiple administrations and multiple diseases, from the early AIDS crisis, when the federal response lagged years behind the epidemiological reality because the disease was disproportionately affecting communities that Washington was reluctant to prioritize, to more recent disputes over how transparently agencies should communicate risk. When public health guidance becomes a political football, the incentive structure inside agencies shifts away from “what does the data say” and toward “what will generate the least political blowback,” and that shift has real consequences for how quickly imported threats get named, tracked, contained and mitigated for public safety.

Infectious Disease Policy

Perhaps the single most consistent failure in American infectious disease policy is what researchers call the “panic-neglect cycle.” Congress appropriates enormous emergency funding during a crisis — billions of dollars flowed toward Ebola response in 2014, toward Zika in 2016, toward COVID-19 starting in 2020 — and then, once the immediate danger recedes from headlines, that funding is allowed to lapse rather than being converted into permanent public health infrastructure. The CDC’s own pandemic preparedness reports have repeatedly noted that emergency supplemental funding is a poor substitute for sustained baseline investment, because it arrives too late to build the workforce, laboratory capacity, and data systems that actually prevent the next crisis from becoming a catastrophe. This cycle shows up starkly in the public health workforce itself. State and local health departments lost tens of thousands of jobs during the austerity years following the 2008 financial crisis, and many of those positions were never restored even as the population — and international travel volume — kept growing. A department that once had a dedicated epidemiologist tracking travel-associated illness might now have that person splitting time across a dozen unrelated duties. When measles cases tied to unvaccinated international travelers turn up, as they periodically do in close-knit communities with pockets of low vaccination coverage, the speed of containment depends heavily on whether the local health department has the staff to trace contacts within days rather than weeks. Too often, it doesn’t. Human travelers are only part of the picture. The United States imports enormous volumes of food, live animals, and animal products every year, and the agencies responsible for screening them — the USDA’s Animal and Plant Health Inspection Service and the FDA’s food safety programs — face their own resource constraints. Zoonotic spillover, where a pathogen jumps from animals to humans, has been the origin story for a striking share of emerging infectious diseases, and inspection regimes for live animal imports and exotic wildlife have long been criticized by public health researchers as inconsistent and under-resourced. The 2003 monkeypox outbreak in the United States, traced back to imported African rodents sold as exotic pets, is a textbook example of how a narrow, easily overlooked import pathway can seed a domestic outbreak with almost no warning or competent over site from our employees. The basic question seeks an answer, why do we need African rodents in the first place?

Public Health Researchers

None of this means the answer is simply “close the borders,” a slogan that tends to substitute for policy rather than constitute one. Public health researchers who study this problem consistently emphasize that travel bans have limited effectiveness once a pathogen is already circulating in multiple countries, and that they can backfire by discouraging affected nations from reporting outbreaks honestly for fear of economic punishment — precisely the opposite of what early warning requires. A more serious posture looks less dramatic and more procedural: sustained, non-emergency funding for the CDC’s global health security programs; a genuinely unified chain of command connecting airport screening, quarantine authority, and local health department follow-up; investment in wastewater and genomic surveillance that can detect a pathogen’s spread regardless of whether any single traveler shows symptoms; and a rebuilt public health workforce that doesn’t have to be reassembled from scratch every time a new threat appears. It’s worth noting that this is a genuinely contested area of policy, and reasonable people disagree about how much of the blame belongs to government oversight versus the simple, stubborn fact of global interconnectedness. Some researchers argue that no realistic surveillance system could fully offset the sheer scale of modern travel — more than a billion international trips occur every year — and that framing outbreaks primarily as a failure of American policy understates how much responsibility rests with the countries where diseases originate and with the underlying biology of pathogens that spread before symptoms even appear. Others caution against narratives that link disease importation too closely to immigration specifically, noting that public health data consistently shows travel volume and global connectivity, not immigration status, as the dominant driver of imported cases, and that policies built on the opposite assumption tend to divert resources toward border theater rather than the surveillance and public health infrastructure that would actually catch the next threat early. Both critiques are worth holding alongside the case for stronger oversight: the goal isn’t to assign blame for its own sake, but to build a system resilient enough that the next John Billy Doe doesn’t have to walk into an emergency room and get sent home and become a plague on a Nation State!

This page is intended solely for ENTERTAINMENT purposes and should be viewed as such. The information provided here is presented to you in a completely FICTIONAL and FANTASY format, designed to entertain rather than inform. It is your responsibility to conduct your own research if you wish to verify the accuracy or truthfulness of any of the content. THE JANE LEIGH EDITORIAL TEAM, make no assertions or claims regarding factual accuracy. We only affirm that this is not FAKE instead, it is carefully crafted shake and bake FICTION meant for your enjoyment. ALL GUEST CONTRIBUTORS, whether they provide articles, comments, links, opinions, videos, and so forth—are sharing their thoughts as a true reflection of their Free Thought, Free Will, and Free Speech. While we may not always fully agree or align with every single expression they share, we deeply respect and uphold their Inalienable Right To Free Self-Expression by deliberate Design. And importantly, we are acknowledging this commitment to YOU–!

https://youtube.com/watch?v=G4d4DuAqXlI%3Ffeature%3Doembed